アップストリームバイオプロセシングの市場規模、シェア、動向分析レポート：製品別、ワークフロー別、使用タイプ別、モード別、地域別、セグメント予測、2024年～2030年

アップストリームバイオプロセシング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のアップストリームバイオプロセシング市場規模は、2024年から2030年にかけて14.3%のCAGRを記録し、2030年までに592億4,000万米ドルに達すると予測されています。

バイオ医薬品の商業的成功と幅広い受容は、いくつかの自社製造および受託製造のバイオ医薬品企業に有利な成長の道を提供しています。さらに、バイオシミラーや生物製剤の需要の高さ、費用対効果の高い改良技術の発売、シングルユースシステムの受け入れ拡大などの要因が重なり、市場の収益実績を押し上げています。

新興企業や新規参入企業は、バイオ製造プラントを新設する際に予算上の制約に直面することが多いです。そのため、これらの事業体は、製造プロセスを受託サービスに委託することでバイオ治療薬のポートフォリオを拡大し、アップストリームバイオプロセシングサービスの収益拡大に貢献しています。

連続的なアップストリームバイオプロセシングは、バイオプロセス産業に大きな利益をもたらしています。バイオリアクター培養の清澄化のために、音響波技術や連続遠心分離のような方法の導入が増加し、清澄化の負担が最小限になる傾向にあります。その結果、細胞培養の密度が高まり、効率的な上流工程が実現します。

タンパク質発現とクローン・スクリーニングに関する細胞株生産性の継続的な進歩により、予測期間中、細胞培養製品のCAGRは最も速いと予想されます。細胞培養は、上流のバイオプロセスにおいて最も困難で重要なステップと考えられているため、技術的な複雑さに関してより多くの注意が必要とされ、その結果、上流のバイオプロセス市場で最大のシェアを占めています。

マルチユースシステムなどの要因は、投資が1回で済み、より大量のバイオプロセスに適用でき、pHと酸素を正確に維持するため、これらのシステムの使用率が高いことです。しかし、従来のステンレス製バイオリアクターからシングルユースバイオリアクターシステムへのパラダイムシフトが、シングルユース分野の有利な成長の要因となっています。

市場開拓の主なプレーヤーは、市場での存在感を強化するために、新規製品の発展、互恵的パートナーシップ、協定、地理的拡大などの戦略的イニシアチブを採用しています。例えば、2019年2月、Danaher Corporationは、GE Life SciencesのBiopharma事業を買収する契約を締結しました。この買収により、ダナハーはGEバイオファーマの細胞培養培地、シングルユース技術、開発機器、消耗品を既存のポートフォリオに加え、市場でのプレゼンスを拡大しました。

アップストリームバイオプロセシング市場レポート・ハイライト

• バイオリアクターの高い入手可能性と、主要プレーヤーによるシングルユース・バイオリアクターの継続的な発売が、バイオリアクターセグメントの顕著な収益シェアの要因となっています。
• 社内でバイオ生産を行うことができる老舗のバイオ医薬品製造企業が存在することが、このセグメントの最大収益シェアにつながっています。
• アウトソーシング分野は、CMOによるシングルユースシステムの工場への統合を通じた投資の増加と製造能力の拡大により、予測期間中に最も高いCAGRで成長すると予想されます。
• 北米が市場を独占し、2023年には36.2%のシェアを占めました。これは、同地域におけるバイオテクノロジーにおける継続的な技術革新とバイオ医薬品に対する嗜好の高まりの結果です。さらに、米国にはバイオ医薬品メーカーが数多く存在し、多くの投資が行われていることも成長を後押ししています。
• アジア太平洋地域は同市場において最も急成長している地域であり、予測期間中にCAGR 17.4％で成長すると予想されます。これは、上流のワークフローにおける工程内管理に使用できる迅速な分析手法に対する認識が高まっているためです。

目次

第1章 アップストリームバイオプロセシング市場：調査手法と範囲

第2章 アップストリームバイオプロセシング市場：エグゼクティブサマリー

• 市場見通し
• セグメント展望
• 競合考察

第3章 アップストリームバイオプロセシング市場：変数、動向、範囲

• 市場系統の見通し
• 市場力学
• アップストリームバイオプロセシング市場分析ツール

第4章 アップストリームバイオプロセシング市場：製品推定・動向分析

• セグメントダッシュボード
• 世界のアップストリームバイオプロセシング市場の製品変動分析
• 世界のアップストリームバイオプロセシング市場の規模と動向分析、製品別、2018～2030年
• バイオリアクター/発酵槽
• 細胞培養製品
• フィルター
• バイオリアクターアクセサリ
• バッグと容器
• その他

第5章 アップストリームバイオプロセシング市場：ワークフローの推定・動向分析

• セグメントダッシュボード
• 世界のアップストリームバイオプロセシング市場のワークフロー変動分析
• 世界のアップストリームバイオプロセシング市場規模と動向分析、ワークフロー別、2018～2030年
• 培地準備
• 細胞培養
• 細胞分離

第6章 アップストリームバイオプロセシング市場：使用タイプの推定・動向分析

• セグメントダッシュボード
• 世界のアップストリームバイオプロセシング市場の使用タイプの変動分析
• 世界のアップストリームバイオプロセシング市場の規模と動向分析、使用タイプ別、2018～2030年
• 多回使用
• 単回使用

第7章 アップストリームバイオプロセシング市場：モードの推定・動向分析

• セグメントダッシュボード
• 世界のアップストリームバイオプロセシング市場モード変動分析
• 世界のアップストリームバイオプロセシング市場の規模と動向分析、モード別、2018～2030年
• 社内
• アウトソーシング

第8章 アップストリームバイオプロセシング市場：地域推定・動向分析

• 地域別市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 市場規模、予測動向分析、2018年から2030年：
• 北米
  • 北米市場推計・予測2018～2030年
  • 米国
  • カナダ
• 欧州
  • 2018年から2030年までの欧州市場推計・予測
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • ノルウェー
  • スウェーデン
• アジア太平洋地域
  • アジア太平洋市場推計・予測2018～2030年
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ラテンアメリカ市場推計・予測2018～2030年
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ市場推計・予測2018年から2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2023年
• 企業プロファイル/上場企業
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Corning Incorporated
  • Sartorius AG
  • Eppendorf AG
  • Danaher
  • Boehringer Ingelheim GmbH
  • Applikon Biotechnology
  • PBS Biotech, Inc.
  • Lonza
  • VWR International, LLC
  • Meissner Filtration Products, Inc.
  • Repligen Corporation
  • Entegris
  • Kuhner AG

List of Tables

• Table 1 List of abbreviations
• Table 2 Global upstream bioprocessing market, by region, 2018 - 2030 (USD Million)
• Table 3 Global upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 4 Global upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 5 Global upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 6 Global upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 7 North America upstream bioprocessing market, by country, 2018 - 2030 (USD Million)
• Table 8 North America upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 9 North America upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 10 North America upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 11 North America upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 12 U.S. upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 13 U.S. upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 14 U.S. upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 15 U.S. upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 16 Canada upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 17 Canada upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 18 Canada upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 19 Canada upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 20 Europe upstream bioprocessing market, by country, 2018 - 2030 (USD Million)
• Table 21 Europe upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 22 Europe upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 23 Europe upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 24 Europe upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 25 Germany upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 26 Germany upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 27 Germany upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 28 Germany upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 29 UK upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 30 UK upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 31 UK upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 32 UK upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 33 France upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 34 France upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 35 France upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 36 France upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 37 Italy upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 38 Italy upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 39 Italy upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 40 Italy upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 41 Spain upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 42 Spain upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 43 Spain upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 44 Spain upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 45 Denmark upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 46 Denmark upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 47 Denmark upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 48 Denmark upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 49 Norway upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 50 Norway upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 51 Norway upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 52 Norway upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 53 Sweden upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 54 Sweden upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 55 Sweden upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 56 Sweden upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific upstream bioprocessing market, by country, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 62 China upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 63 China upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 64 China upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 65 China upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 66 Japan upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 67 Japan upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 68 Japan upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 69 Japan upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 70 India upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 71 India upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 72 India upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 73 India upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 74 South Korea upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 75 South Korea upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 76 South Korea upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 77 South Korea upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 78 Australia upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 79 Australia upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 80 Australia upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 81 Australia upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 82 Thailand upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 83 Thailand upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 84 Thailand upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 85 Thailand upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 86 Latin America upstream bioprocessing market, by country, 2018 - 2030 (USD Million)
• Table 87 Latin America upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 88 Latin America upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 89 Latin America upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 90 Latin America upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 91 Brazil upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 92 Brazil upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 93 Brazil upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 94 Brazil upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 95 Mexico upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 96 Mexico upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 97 Mexico upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 98 Mexico upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 99 Argentina upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 100 Argentina upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 101 Argentina upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 102 Argentina upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 103 MEA upstream bioprocessing market, by country, 2018 - 2030 (USD Million)
• Table 104 MEA upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 105 MEA upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 106 MEA upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 107 MEA upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 108 South Africa upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 109 South Africa upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 110 South Africa upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 111 South Africa upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 112 Saudi Arabia upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 116 UAE upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 117 UAE upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 118 UAE upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 119 UAE upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
• Table 120 Kuwait upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
• Table 121 Kuwait upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
• Table 122 Kuwait upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
• Table 123 Kuwait upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Upstream bioprocessing market segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research process
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modelling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market snapshot
• Fig. 13 Segment snapshot 1
• Fig. 14 Segment snapshot 2
• Fig. 15 Competitive landscape snapshot
• Fig. 16 Biotechnology market value, 2023 (USD billion)
• Fig. 17 Market trends & outlook
• Fig. 18 PESTEL analysis
• Fig. 19 Porter's Five Forces analysis
• Fig. 20 Upstream bioprocessing market: Product outlook & key takeaways
• Fig. 21 Upstream bioprocessing market: Product movement analysis
• Fig. 22 Global bioreactors/fermenters market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Global cell culture products market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Global filters market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Global bioreactors accessories market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Global bags & containers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Global others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Upstream bioprocessing market: Workflow outlook & key takeaways
• Fig. 29 Upstream bioprocessing market: Workflow movement analysis
• Fig. 30 Global media preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Global cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Global cell separation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Upstream bioprocessing market: Use type outlook & key takeaways
• Fig. 34 Upstream bioprocessing market: Use type movement analysis
• Fig. 35 Global multi-use market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Global single-use market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Upstream bioprocessing market: Mode outlook & key takeaways
• Fig. 38 Upstream bioprocessing market: Mode movement analysis
• Fig. 39 Global in-house market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Global outsourced market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 41 Regional marketplace outlook, 2023 & 2030 (USD Billion)
• Fig. 42 Regional marketplace: Key takeaways
• Fig. 43 North America upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Key country dynamics
• Fig. 45 U.S. upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Key country dynamics
• Fig. 47 Canada upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Europe upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Key country dynamics
• Fig. 50 Germany upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Addressable aspects of upstream process: Sartorius AG
• Fig. 52 Key country dynamics
• Fig. 53 UK upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Key country dynamics
• Fig. 55 France upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Key country dynamics
• Fig. 57 Italy upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 Spain upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 Denmark upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Key country dynamics
• Fig. 63 Norway upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 Sweden upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Asia Pacific upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Key country dynamics
• Fig. 68 Japan upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 China upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 India upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Key country dynamics
• Fig. 74 Australia upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Key country dynamics
• Fig. 76 Thailand upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Key country dynamics
• Fig. 78 South Korea upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Latin America upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 Brazil upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 Mexico upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Key country dynamics
• Fig. 85 Argentina upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 MEA upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 87 Key country dynamics
• Fig. 88 South Africa upstream bioprocessing materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89 Key country dynamics
• Fig. 90 Saudi Arabia upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 91 Key country dynamics
• Fig. 92 UAE upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 93 Key country dynamics
• Fig. 94 Kuwait upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 95 Market participant categorization
• Fig. 96 Global upstream bioprocessing market position analysis, 2023
• Fig. 97 Strategic framework

Upstream Bioprocessing Market Growth & Trends:

The global upstream bioprocessing market size is expected to reach USD 59.24 billion by 2030, registering a CAGR of 14.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Commercial success and wide acceptance of biopharmaceuticals have provided lucrative growth avenues to several in house as well as contract manufacturing biopharmaceutical companies. Furthermore, a confluence of factors, such as high demand for biosimilars and biologics, launch of improved cost-effective technologies, and growing acceptance of single-use systems have driven the revenue performance of the market.

Start-ups and new market entrants often face budget constraints while establishing new biomanufacturing plants. Thus, these entities expand their biotherapeutics portfolio by outsourcing the production process to contract services, thereby aiding in revenue growth for upstream bioprocessing services.

Continuous upstream bioprocessing has greatly benefited the bioprocessing industry. Rising implementation of methods, such as acoustic wave technology and continuous centrifugation, for clarification of bioreactor cultures tends to minimize the clarification burden. This, in turn, increases the cell-culture densities, consequently resulting in efficient upstream processes.

Ongoing advancements in cell line productivity with respect to protein expression and clone screening are expected to result in the fastest CAGR of cell culture products over the forecast period. Cell culture is considered as the most challenging and crucial step in upstream bioprocessing, and thus demands more attention with respect to technological intricacies, resulting in the largest share in the upstream bioprocessing market.

Factors such as multi-use systems incur one-time investment, are applicable for larger bioprocessing volumes and maintain the pH and oxygen accurately resulting in high usage rate of these systems. However, a paradigm shift from conventional stainless-steel bioreactors to single-use bioreactor systems has attributed to the lucrative growth of the single-use segment.

Key market players are adopting strategic initiatives, such as novel product developments, mutually beneficial partnerships, agreements, and geographical expansion to reinforce their market presence. For instance, in February 2019, Danaher Corporation signed an agreement to acquire the Biopharma business of GE Life Sciences. The acquisition broadened Danaher's market presence with the addition of GE Biopharma's cell culture media, single-use technologies, development instrumentation, and consumables to its existing portfolio.

Upstream Bioprocessing Market Report Highlights:

• High availability of bioreactors and continuous launches of single-use bioreactors by the key market players can be attributed to the remarkable revenue share of the bioreactors segment
• Presence of well-established biopharmaceutical manufacturing firms capable of performing in-house bioproduction has led to the maximum revenue share of this segment
• The outsourced segment is expected to grow at the highest CAGR over the forecast period, owing to increase in investments and expansion of manufacturing capabilities through the integration of single-use systems in the plants by CMOs
• North America dominated the market and accounted for a share of 36.2% in 2023 as a result of the continuous innovations in biotechnology and rising preferences for biopharmaceuticals in the region. Moreover, the presence of substantial in-house biopharmaceutical manufacturers coupled with numerous investments in the U.S. biologics market has driven the growth
• Asia Pacific is expected to be the fastest-growing region in the market and is expected to grow at a CAGR of 17.4% during the forecast period due to growing awareness about the rapid analytical methods that can be used for in-process control during the upstream workflows

Table of Contents

Chapter 1. Upstream Bioprocessing Market: Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Workflow
  • 1.1.3. Use Type
  • 1.1.4. Mode
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Upstream Bioprocessing Market: Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Workflow outlook
  • 2.2.3. Use type outlook
  • 2.2.4. Mode outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Upstream Bioprocessing Market: Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Upstream Bioprocessing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Upstream Bioprocessing Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Upstream Bioprocessing Market Product Movement Analysis
• 4.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Bioreactors/Fermenters
  • 4.4.1. Bioreactors/fermenters market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Cell Culture Products
  • 4.5.1. Cell Culture Products market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Filters
  • 4.6.1. Filters market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Bioreactors Accessories
  • 4.7.1. Bioreactors accessories market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Bags & Containers
  • 4.8.1. Bags & containers market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Upstream Bioprocessing Market: Workflow Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Upstream Bioprocessing Market Workflow Movement Analysis
• 5.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
• 5.4. Media Preparation
  • 5.4.1. Media preparation market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Cell Culture
  • 5.5.1. Cell culture market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Cell Separation
  • 5.6.1. Cell separation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Upstream Bioprocessing Market: Use Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Upstream Bioprocessing Market Use Type Movement Analysis
• 6.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Use Type, 2018 to 2030 (USD Million)
• 6.4. Multi-use
  • 6.4.1. Multi-use market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Single-use
  • 6.5.1. Single-use market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Upstream Bioprocessing Market: Mode Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Upstream Bioprocessing Market Mode Movement Analysis
• 7.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Mode, 2018 to 2030 (USD Million)
• 7.4. In-house
  • 7.4.1. In-house market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Outsourced
  • 7.5.1. Outsourced market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Upstream Bioprocessing Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.4. North America
  • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Regulatory framework
  • 8.4.3. Canada
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. Regulatory framework
• 8.5. Europe
  • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Regulatory framework
  • 8.5.3. Germany
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Regulatory framework
  • 8.5.4. France
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Regulatory framework
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. Regulatory framework
  • 8.5.6. Spain
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Regulatory framework
  • 8.5.7. Denmark
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7.3. Competitive scenario
    • 8.5.7.4. Regulatory framework
  • 8.5.8. Norway
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8.3. Competitive scenario
    • 8.5.8.4. Regulatory framework
  • 8.5.9. Sweden
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.9.3. Competitive scenario
    • 8.5.9.4. Regulatory framework
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Regulatory framework
  • 8.6.3. China
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. Regulatory framework
  • 8.6.4. India
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Regulatory framework
  • 8.6.5. Australia
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Regulatory framework
  • 8.6.6. South Korea
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Regulatory framework
  • 8.6.7. Thailand
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Regulatory framework
• 8.7. Latin America
  • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Regulatory framework
  • 8.7.3. Mexico
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. Regulatory framework
  • 8.7.4. Argentina
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Regulatory framework
• 8.8. MEA
  • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Regulatory framework
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. Regulatory framework
  • 8.8.4. UAE
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4.3. Competitive scenario
    • 8.8.4.4. Regulatory framework
  • 8.8.5. Kuwait
    • 8.8.5.1. Key country dynamics
    • 8.8.5.2. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.5.3. Competitive scenario
    • 8.8.5.4. Regulatory framework

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2023
• 9.4. Company Profiles/Listing
  • 9.4.1. Thermo Fisher Scientific, Inc.
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Merck KGaA
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Corning Incorporated
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Sartorius AG
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Eppendorf AG
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Danaher
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Boehringer Ingelheim GmbH
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Applikon Biotechnology
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. PBS Biotech, Inc.
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Lonza
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives
  • 9.4.11. VWR International, LLC
    • 9.4.11.1. Company overview
    • 9.4.11.2. Financial performance
    • 9.4.11.3. Product benchmarking
    • 9.4.11.4. Strategic initiatives
  • 9.4.12. Meissner Filtration Products, Inc.
    • 9.4.12.1. Company overview
    • 9.4.12.2. Financial performance
    • 9.4.12.3. Product benchmarking
    • 9.4.12.4. Strategic initiatives
  • 9.4.13. Repligen Corporation
    • 9.4.13.1. Company overview
    • 9.4.13.2. Financial performance
    • 9.4.13.3. Product benchmarking
    • 9.4.13.4. Strategic initiatives
  • 9.4.14. Entegris
    • 9.4.14.1. Company overview
    • 9.4.14.2. Financial performance
    • 9.4.14.3. Product benchmarking
    • 9.4.14.4. Strategic initiatives
  • 9.4.15. Kuhner AG
    • 9.4.15.1. Company overview
    • 9.4.15.2. Financial performance
    • 9.4.15.3. Product benchmarking
    • 9.4.15.4. Strategic initiatives